Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation
- PMID: 24423786
- DOI: 10.1016/j.nlm.2013.12.015
Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation
Abstract
Atypical antipsychotics fail to substantially improve cognitive impairment associated with schizophrenia (CIAS) and one strategy to improve it is to stimulate adult neurogenesis in hippocampus, because this structure is part of an altered circuitry that underlies aspects of CIAS. Deficits in hippocampal adult neurogenesis may disrupt cognitive processes that are dependent on newborn neurons, such as pattern separation (the formation of distinct representations of similar inputs). Mechanisms by which hippocampal adult neurogenesis can be increased are therefore of therapeutic interest and a promising molecular target is the activation of serotonin 5-HT(1A) receptors because agonists at this site increase adult neuronal proliferation in the dentate gyrus. We hypothesize that use of antipsychotics possessing 5-HT(1A) receptor agonist properties may protect against or attenuate CIAS by a dual mechanism: a favorable influence on adult neurogenesis that develops upon sustained drug treatment, and an increase in dopamine levels in the prefrontal cortex that starts upon acute treatment. This hypothesis is consistent with the beneficial properties of 5-HT(1A) activation reported from pilot clinical studies using 5-HT(1A) agonists as adjunct to antipsychotic treatments. Recent antipsychotics, including clozapine and aripiprazole, exhibit different levels of 5-HT(1A) receptor partial agonism and may, therefore, differentially elicit hippocampal adult neurogenesis and increases in prefrontal cortex dopamine. We suggest that comparative studies should elucidate correlations between effects of antipsychotics on adult neurogenesis and prefrontal cortex dopamine with effects on performance in translational cognitive tasks known to involve new born neurons, such as tasks involving pattern separation, and working memory tasks sensitive to prefrontal cortex dopamine levels.
Keywords: Atypical antipsychotics; CIAS; Declarative memory; Hippocampus; Pattern separation; Tri-synaptic pathway.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?Behav Brain Res. 2008 Dec 16;195(1):98-102. doi: 10.1016/j.bbr.2008.05.016. Epub 2008 May 29. Behav Brain Res. 2008. PMID: 18707769 Review.
-
Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.Adv Ther. 2008 Oct;25(10):1037-56. doi: 10.1007/s12325-008-0102-2. Adv Ther. 2008. PMID: 18839076 Review.
-
Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation.Brain Res. 2005 May 10;1043(1-2):32-41. doi: 10.1016/j.brainres.2005.02.072. Brain Res. 2005. PMID: 15862515
-
Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.Eur J Pharmacol. 2004 Jun 16;493(1-3):75-83. doi: 10.1016/j.ejphar.2004.04.028. Eur J Pharmacol. 2004. PMID: 15189766
-
Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.J Neurochem. 2014 Mar;128(6):938-49. doi: 10.1111/jnc.12512. Epub 2013 Nov 14. J Neurochem. 2014. PMID: 24164459
Cited by
-
Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia.Neuropsychiatr Dis Treat. 2015 Feb 20;11:453-9. doi: 10.2147/NDT.S76494. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 25759587 Free PMC article.
-
One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia.Neuropsychopharmacology. 2020 Jul;45(8):1362-1368. doi: 10.1038/s41386-020-0685-0. Epub 2020 Apr 29. Neuropsychopharmacology. 2020. PMID: 32349117 Free PMC article. Clinical Trial.
-
Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia.Int J Mol Sci. 2023 Mar 21;24(6):5945. doi: 10.3390/ijms24065945. Int J Mol Sci. 2023. PMID: 36983018 Free PMC article.
-
Augmentation Therapy With Serotonin 5-HT1A Receptor Partial Agonists on Cognitive Function in Depressive Disorders: A Systematic Review of Randomized Controlled Studies.Neuropsychopharmacol Rep. 2025 Jun;45(2):e70023. doi: 10.1002/npr2.70023. Neuropsychopharmacol Rep. 2025. PMID: 40421605 Free PMC article. Review.
-
Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task.Br J Pharmacol. 2015 May;172(10):2532-43. doi: 10.1111/bph.13071. Epub 2015 Feb 27. Br J Pharmacol. 2015. PMID: 25572672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical